hCAI/II-IN-6

• CAT Number: I042880
• CAS Number: 694466-00-7
• Molecular Formula: C19H24N4O3S
• Molecular Weight: 388.48
• Purity: ≥95%
• Synonyms: 2-(4-benzylpiperazin-1-yl)-N-(4-sulfamoylphenyl)acetamide
• InChI: InChI=1S/C19H24N4O3S/c20-27(25,26)18-8-6-17(7-9-18)21-19(24)15-23-12-10-22(11-13-23)14-16-4-2-1-3-5-16/h1-9H,10-15H2,(H,21,24)(H2,20,25,26)
• InChIKey: VMBFFHZLNCWIEC-UHFFFAOYSA-N
• SMILES: C1CN(CCN1CC2=CC=CC=C2)CC(=O)NC3=CC=C(C=C3)S(=O)(=O)N

hCAI/II-IN-6（Cat No.:I042880）is a small molecule inhibitor designed to target human carbonic anhydrases I and II (hCAI and hCAII). These enzymes play key roles in regulating pH balance and ion transport within cells, and are involved in various physiological processes, including respiration, renal function, and bone resorption. Inhibition of hCAI and hCAII has potential therapeutic applications in conditions such as glaucoma, cancer, and osteoporosis. hCAI/II-IN-6 has shown promise in preclinical studies as a potent and selective inhibitor, with ongoing research focused on its efficacy, safety, and potential clinical uses.